Oncternal Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Oncternal Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • Oncternal Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 2.96M shares, a 95% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 2.96M -56M -95% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 2.96M -55.8M -95% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 2.96M -55.8M -95% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 2.95M +74K +2.58% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 59M +3.45M +6.22% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 58.7M +6.58M +12.6% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 58.7M +9.28M +18.8% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 2.87M -46.6M -94.2% Dec 31, 2022 10-K 2024-03-07
Q3 2022 55.5M +6.09M +12.3% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 52.2M +2.77M +5.6% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 49.4M +63K +0.13% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 49.4M +627K +1.29% Dec 31, 2021 10-K 2023-03-09
Q3 2021 49.4M +27.1M +121% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 49.4M +32M +185% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 49.4M +34M +221% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 48.8M +33.4M +217% Dec 31, 2020 10-K 2022-03-10
Q3 2020 22.3M +6.96M +45.2% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 17.3M +1.97M +12.8% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 15.4M -8.66M -36% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 15.4M +11.6M +309% Dec 31, 2019 10-K/A 2021-03-12
Q3 2019 15.4M -8.66M -36% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 15.4M -8.66M -36% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 24.1M +1.52M +6.76% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 3.76M -17.8M -82.5% Dec 31, 2018 10-K 2020-03-16
Q3 2018 24.1M +2.51M +11.7% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 24M +7.99M +49.8% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 22.5M +6.49M +40.4% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 21.5M +5.62M +35.3% Dec 31, 2017 10-K 2019-03-18
Q3 2017 21.5M -120M -84.8% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 16M -126M -88.7% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 16M -126M -88.7% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 15.9M +1.88M +13.4% Dec 31, 2016 10-K 2018-03-13
Q3 2016 142M +1.54M +1.1% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 142M +1.38M +0.98% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 142M +1.38M +0.98% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 14M -126M -90% Dec 31, 2015 10-K 2017-03-24
Q3 2015 140M +64.4M +84.7% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 140M +64.4M +84.7% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 140M +65.2M +86.8% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 140M +77.1M +122% Dec 31, 2014 10-K 2016-03-15
Q3 2014 76M +12.8M +20.3% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 76M +12.9M +20.4% Jun 30, 2014 10-Q 2014-08-05
Q1 2014 75.2M +12.3M +19.5% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 63.2M +367K +0.58% Dec 31, 2013 10-K 2015-03-16
Q3 2013 63.2M +368K +0.59% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 63.1M +301K +0.48% Jun 30, 2013 10-Q 2013-07-22
Q1 2013 62.9M +90.1K +0.14% Mar 31, 2013 10-Q 2013-05-06
Q4 2012 62.8M +28.2K +0.05% Dec 31, 2012 10-K 2014-03-12
Q3 2012 62.8M +26.7K +0.04% Sep 30, 2012 10-Q 2012-11-08
Q2 2012 62.8M +53.3K +0.09% Jun 30, 2012 10-Q 2012-08-08
Q1 2012 62.8M Mar 31, 2012 10-Q 2012-05-10
Q4 2011 62.8M +11.1M +21.4% Dec 31, 2011 10-K 2013-03-05
Q3 2011 62.8M Sep 30, 2011 10-Q 2011-11-04
Q2 2011 62.8M Jun 30, 2011 10-Q 2011-08-09
Q4 2010 51.7M Dec 31, 2010 10-K 2012-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.